News Archives - AudioMedica.com

Tagged: News

0
- in Oncology
- — 3 Jun, 2008
Audio Journal of Oncology Volume 16 Number 11
Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
Sarah Maxwell and Peter Goodwin report from: American Society of Clinical Oncology Annual Meeting, May 30-June 3, 2008, Chicago
Michael Gnant
In this edition:
1. Zoledronic …
Read more
0
- in Oncology
- — 26 Apr, 2008
Audio Journal of Oncology Volume 16 Number 9
Scientific Editors: George Canellos (Boston), Pat Price (Manchester), Gianni Bonadonna (Milan), Gordon McVie (Milan)
Commenting Expert: Emiel Rutgers, Netherlands Cancer Institute, Amsterdam
Angel Rodriguez
In this edition:
1. Lapatinib: Targets Breast Cancer Stem Cells?
Angel Rodriguez, Baylor College, Houston…
Read more
0
- in London School of Hygiene & Tropical Medicine
- — 9 Apr, 2008
Risks From Stopping Cancer Trials Early!

Giovanni Apolone
In this edition of Audio News, presented by Peter Goodwin, Giovanni Apolone (Mario Negri Institute, Milan) and Stuart Pocock (London School of Hygiene and Tropical Medicine), talk about:
Risks From Stopping Cancer Trials Early!
– A report from
…
Read more
Dasatinib Effective At Two Yearsâ€™ Follow Up in Chronic Phase CML" /> 0
- in Oncology
- — 10 Dec, 2007
Live Report from ASH:
Dasatinib Effective At Two Yearsâ€™ Follow Up in Chronic Phase CML

Richard Stone
RICHARD STONE, Dana-Farber Cancer Institute, Boston
GEORGE CANELLOS, Dana-Farber Cancer Institute
New data shows that dasatinib is giving durable responses in patients with chronic phase chronic myeloid leukemia who have failed, or who cannot tolerate imatinib. So where
…
Read more
0
- in Oncology
- — 10 Dec, 2007
Live Report from ASH: Azacitidine â€˜New Standardâ€™ In High Risk Myelodysplastic Syndromes

Pierre Fenaux
PIERRE FENAUX, Paris 13 University
Results from a phase III study presented at ASH suggest that the hypomethylating agent azacitidine should be the new standard of care for patients with high-risk MDS. Pierre Fenaux of Paris 13 University
…
Read more
Interleukin-2 For Acute Myeloid Leukemia In First Remission?" /> 0
- in Oncology
- — 10 Dec, 2007
Live Report from ASH:
Interleukin-2 For Acute Myeloid Leukemia In First Remission?

Jonathan Kolitz
JONATHAN KOLITZ, Monter Cancer Center, Lake Success, NY
GEORGE CANELLOS, Dana-Farber Cancer Institute
For patients with acute myeloid leukemia in first remission, new data suggests that there may be a benefit from interleukin-2. Derek Thorne got the interim
…
Read more
1
- in General Medicine
- — 9 Dec, 2007
New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura

Terry Gernsheimer
TERRY GERNSHEIMER, University of Washington Medical Center, Seattle
An investigational drug AMG 531 has increased and sustained platelet counts in splenectomized patients with chronic immune thrombocytopenic purpura or ITP. This was in a placebo controlled phase III trial
…
Read more
1
- in Public Health
- — 9 Dec, 2007
No Use Of Hydroxyurea In Country With Most Sickle Cell Anemia

Zakari Aliyu
REFERENCE: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta
ZAKARI ALIYU, Howard University, Washington DC
Nigeria has the highest incidence of sickle cell anemia in the world, with over 150,000 children being born each year with
…
Read more
0
- in Cardiovascular
- — 5 Nov, 2007
TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention?

Gordon Tomaselli

Daniel Jones
REFERENCE: Late Breaking Clinical Trials 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
GORDON TOMASELLI, Johns Hopkins University, Baltimore
COMMENT: DANIEL JONES, President, American Heart Association, University of Mississippi, Jackson
A potential new
…
Read more
0
- in Oncology
- — 16 Oct, 2007
Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer

Jose Baselga

Gordon McVie
REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 â€“ 27 September 2007
JOSE BASELGA, Vall dâ€™Hebron University Hospital, Barcelona
COMMENT: GORDON MCVIE, European Institute of Oncology, Milan
Neoadjuvant trastuzumab for patients with HER2-positive
…
Read more
0
- in Oncology
- — 26 Sep, 2007
Laparoscopic-Assisted Resection for Colorectal Cancer

Pierre Guillou

David Jayne
REFERENCE: J Clin Oncol 25:3061-3068
PIERRE GUILLOU, St James’ Hospital, Leeds
COMMENT: DAVID JAYNE, St James’ Hospital, Leeds
Laparoscopic-assisted resection for colorectal cancer has proved just as effective as conventional open surgery, according to researchers in
…
Read more
0
- in Public Health
- — 19 Sep, 2007
Vancomycin: New Guidelines May Induce Kidney Damage

Megan Nguyen
REFERENCE: Poster Session 104 K-1096, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
MEGAN NGUYEN, Western University in Pomona, California
New vancomycin guidelines that recommend using higher doses may cause kidney damage according to
…
Read more

Tagged: News

Sign up for AudioMedica.com news